Dermata warrants removed from Nasdaq listing

Dermata Therapeutics, Inc. is having its warrant class removed from listing and registration on the Nasdaq Stock Market LLC under Section 12(b) of the Securities Exchange Act of 1934.

Rhea-AI Filing Summary

Dermata Therapeutics, Inc. is having its warrant class removed from listing and registration on the Nasdaq Stock Market LLC under Section 12(b) of the Securities Exchange Act of 1934. Nasdaq states it has complied with its own rules to strike this class of securities, and the company has complied with exchange rules and SEC requirements governing voluntary withdrawal.

Key Terms

Form 25, Section 12(b) of the Securities Exchange Act of 1934, voluntary withdrawal of the class of securities from listing and registration

3 terms

Form 25 regulatory

"FORM 25 NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION"

A Form 25 is an official filing with the U.S. Securities and Exchange Commission used to remove a company's stock or other security from a national exchange list. Investors should care because delisting often means less visibility, lower trading volume and wider price swings—similar to a product moving from a major supermarket to a small local market, which can make buying, selling and valuing the security more difficult.

Section 12(b) of the Securities Exchange Act of 1934 regulatory

"REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934"

voluntary withdrawal of the class of securities from listing and registration regulatory

"governing the voluntary withdrawal of the class of securities from listing"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Dermata Therapeutics, Inc. (DRMA) report in this Form 25 filing?

Dermata Therapeutics reports that its warrant class is being removed from Nasdaq listing and Section 12(b) registration. Nasdaq and the company state they have complied with applicable exchange rules and SEC Rule 12d2-2 requirements for this withdrawal.

Which Dermata Therapeutics (DRMA) security is affected by this Nasdaq removal?

The filing covers Dermata Therapeutics’ warrants as the affected class of securities. It specifies that this warrant class is being struck from listing and withdrawn from registration on the Nasdaq Stock Market LLC under Section 12(b).

Who is the exchange involved in Dermata Therapeutics (DRMA) Form 25 delisting?

The exchange involved is the Nasdaq Stock Market LLC. Nasdaq certifies it has reasonable grounds to file Form 25 and that it has followed its rules to strike Dermata’s warrant class from listing and registration under Section 12(b).

Is the Dermata Therapeutics (DRMA) warrant removal from Nasdaq voluntary?

The filing states that, under 17 CFR 240.12d2-2(c), the issuer has complied with the exchange’s rules and SEC requirements governing the voluntary withdrawal of this warrant class from listing and registration on Nasdaq.

What SEC rules are cited in Dermata Therapeutics (DRMA) Form 25?

The notification references 17 CFR 240.12d2-2(a), 12d2-2(b), and 12d2-2(c). These provisions govern how exchanges and issuers remove a class of securities from listing and withdraw registration under Section 12(b) of the Exchange Act.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/17/2026 - 04:23 PM Accepted by SEC EDGAR 08/17/2026 - 04:22 PM Learn about SEC filing dates

UNITED STATES

OMB APPROVAL

OMB Number:			3235-0080
Expires:	March 31, 2018
Estimated average burden
hours per response:			1.7

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 25

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number

001-40739

Issuer:	Dermata Therapeutics, Inc.
Exchange:	Nasdaq Stock Market LLC

(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)

Address:	3525 Del Mar Heights Rd., #322
	San Diego	CALIFORNIA	92130
Telephone number:					(858) 800-2543

(Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)

Warrant

(Description of class of securities)

Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:

17 CFR 240.12d2-2(a)(1)

17 CFR 240.12d2-2(a)(2)

17 CFR 240.12d2-2(a)(3)

17 CFR 240.12d2-2(a)(4)

Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. ¹

Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.

Pursuant to the requirements fo the Securities Exchange Act of 1934, Nasdaq Stock Market LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.

2026-08-17	By	Tara Petta		AVP
Date		Name		Title

¹ Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.